Novavax, Inc. (NVAX) NASDAQ
10.21
-0.3(-2.85%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.09B |
| Enterprise Value | 1.1B |
| P/E Ratio | -18.98 |
| PEG Ratio | 0.16 |
| Price/Sales Ratio | 2.82 |
| Price/Book Ratio | -11.52 |
| Enterprise/Revenue | 2.93 |
| Enterprise/EBITDA | -30.62 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.15 |
| Operating Margin | -0.11 |
Management Effectiveness
| Return On Assets | -0.08 |
| Return On Equity | 0.9 |
Income Statement
| Revenue | 1.12B |
| Revenue/Share | 3.65 |
| Gross Profit | 1.05B |
| EBITDA | 492.33M |
| Net Income | 440.3M |
| Diluted EPS | 2.54 |
Balance Sheet
| Total Cash | 790.33M |
| Total Cash/Share | 4.84 |
| Total Debt | 295.06M |
| Total Debt/Equity | -2.04 |
| Current Ratio | 2.48 |
| Book Value Per Share | -0.89 |
Price History
| 52-Week Change | 40.63 |
| 52-Week High | 11.97 |
| 52-Week Low | 6.13 |
| Moving Average 50 Days | 8.87 |
| Moving Average 200 Days | 8.4 |
Statistics
| Average Volume | 4.62M |
| Shares Outstanding | 164.44M |
| % Held by Institutions | 72.84 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | May 10, 2019 |
